Our cycloheximide chase analysis results showed that inhibition of ERK phosphorylation by MEK inhibitor treatment dramatically enhanced Lgr4 protein stability in BRAFV600E-mutant CRC cell line HT29 cells (Figure 5I). The gene discussed is LGR4; the disease is colorectal carcinoma.